Highest-materiality recent filing
Director Lewis Titterton retires; Anthony Bowers appointed to ParkerVision board
Lewis Titterton resigned as director and from Audit/Compensation committees on May 15, 2026, citing retirement, no disagreement.
ParkerVision reports Q1 net loss $1.6M; Qualcomm appeal oral arguments June 1
Net loss of $1.6M ($0.01/share) for Q1 2026 vs. $3.8M loss a year ago; decrease driven by $2.1M fair value adjustment on contingent obligations.
ParkerVision extends CEO and CFO stock option expiration to 2029; records $360K non-cash charge
CEO Jeffrey Parker's 2,660,000 options and CFO Cynthia French's 870,550 options extended from Aug 7, 2026 to Aug 7, 2029.
ParkerVision reports $7.4M net loss; Qualcomm appeal expedited, MediaTek trial postponed
Net loss of $7.4M ($0.06/share) vs. $14.5M loss in 2024; improvement driven by $0.6M gain on contingent payment obligations.
ParkerVision exchanges $688K in notes+interest for 3.28M shares at $0.21/share
Aggregate outstanding principal of $675,000 and accrued interest of $13,200 exchanged for 3,277,099 common shares.
CEO Jeffrey Parker receives option for up to 8M shares at $0.24; CFO Cynthia French receives option for 500K shares at same price.
ParkerVision closes $3.46M registered direct offering of 16.5M shares at $0.21/share
Sold 16,481,579 shares at $0.21 each for gross proceeds of ~$3.46M to accredited and institutional investors.
ParkerVision Raises $3.46M in Registered Direct Offering of 16.48M Shares
Sold 16,481,579 shares at $0.21 per share, generating ~$3.46M in aggregate proceeds.
ParkerVision raises $1M via stock sale to director Titterton at $0.21/share
Director Lewis Titterton Jr. agrees to purchase 4,761,905 shares at $0.21/share for an aggregate $1,000,000.
ParkerVision sells $1M common stock to director at $0.21/share
Closed sale of 4,761,905 shares to independent director Lewis H. Titterton, Jr. for $1M gross proceeds.
ParkerVision reports Q3 2025 net loss of $2.0M; updates on Qualcomm appeal and upcoming trials
Net loss $2.0M ($0.02/share) in Q3 2025 vs $10.8M ($0.12/share) in Q3 2024; improvement from lower fair-value loss on contingent payment obligations.
Shareholders elected Paul A. Rosenbaum and Robert G. Sterne as Class III directors with over 19.3 million votes for each.
ParkerVision Q2 net loss $1.6M; patent litigation updates on Qualcomm, Realtek, MediaTek
Net loss $1.6M for Q2 2025 ($0.01/share) vs $0.3M loss in Q2 2024; H1 2025 loss $5.4M ($0.05/share).
ParkerVision board approves increase in equity plan share reserve from 30M to 45M shares
Board amended 2019 Long-Term Incentive Plan on June 10, 2025, raising share reserve from 30M to 45M.
ParkerVision Q1 net loss widens to $3.8M; litigation updates on Qualcomm & Texas cases
Net loss of $3.8M ($0.03/share) vs $0.7M loss in Q3 2024; increase largely due to $2.5M non-cash fair value adjustment.
ParkerVision board member resigns; CEO and CFO get salary increases and option extension
Director Sanford Litvack resigned from board and committees effective April 15, 2025, with no disagreement.
ParkerVision reports 2024 net loss of $14.5M; patent case against Qualcomm remanded for trial
Net loss of $14.5M ($0.16 loss per share) vs net income of $9.5M ($0.11 EPS) in 2023.
ParkerVision launches "Against the Giants" video series on Qualcomm litigation
First episode of four-part series now live on @Against_Giants on X and Instagram.
ParkerVision awards CEO $350K, CFO $100K one-time bonuses for strategic contributions
CEO Jeffrey Parker received $350K and CFO Cynthia French $100K in one-time discretionary cash bonuses on Jan 15, 2025.
ParkerVision raises $5M through private placement of 10M shares and 2M warrants at $0.50/share
Raised $5M aggregate proceeds from sale of 10,000,000 shares and 2,000,000 warrants at $0.50/share.
ParkerVision appoints Frazier & Deeter as new independent auditor for FY 2024
Audit committee approved appointment of Frazier & Deeter on Nov 12; finalized Dec 16-17, 2024.
ParkerVision reports Q3 net loss of $10.8M; CAFC rules favorably in Qualcomm case
Net loss of $10.8M ($0.12/share) for Q3 2024 vs $3.9M loss in Q3 2023.
MSL, P.A. notified ParkerVision on Nov 1, 2024 that it will cease as auditor after completing Q3 2024 review due to its merger with Forvis Mazars, LLP.
ParkerVision auditor MSL absorbed by Forvis Mazars; successor search started
Auditor MSL, P.A. will cease after completing Q3 2024 review; all MSL staff join Forvis Mazars.
Shareholders authorize increase in Parkervision common stock to 225M shares
Approved amendment raising authorized common stock from 175M to 225M; effective Oct 30, 2024.
ParkerVision wins CAFC appeal; Qualcomm patent case remanded for trial in Florida
CAFC reversed district court's Daubert exclusion of expert testimony, reinstating infringement claims.
ParkerVision Q2 net loss $0.3M vs year-ago net income; patent litigation updates
Net loss of $0.3M ($0.00 per share) for Q2 2024 vs net income of $1.4M ($0.02) in Q2 2023.
Extended $500K 2019 note maturity to Dec 1, 2024; auto-renewable to July 2025, then up to ten 1-yr extensions at 7.5% interest.
ParkerVision extends three convertible notes totaling $350k to Dec 1, 2024
$150k note from June 2019 extended from June 7 to Dec 1, 2024; conversion price $0.10 unchanged.
ParkerVision Q1 net loss $0.7M; patent trials set for Dec 2024, Jan 2025
Net loss $0.7M ($0.01/share) vs net income $13.1M ($0.16/share) in Q1 2023, which included a $25M patent settlement.
ParkerVision reports 2023 net income of $9.5M vs loss of $9.8M in 2022; patent trial dates set
Net income $9.5M (EPS $0.11 basic, $0.08 diluted) vs net loss $9.8M in 2022.
ParkerVision extends warrant expiration to June 2025 for Brickell Key Investments
Warrant amendment extends expiration from Dec 20, 2023 to June 20, 2025.
ParkerVision reports $10.6M net income for 9 months; Q3 loss $3.9M; patent case updates
Net income of $10.6M ($0.12/share) for nine months ended Sep 30, 2023, vs net loss of $4.5M prior year.
Amended $425K notes: conversion price cut from $0.57 to $0.25/share, maturity extended to March 18, 2026.
ParkerVision posts $14.5M net income in H1 2023 on $25M patent license deal
Q2 2023 net income of $1.4M ($0.02/share) vs. Q2 2022 net loss of $4.4M ($0.06/share).
ParkerVision awards $116K in cash bonuses to CEO and CFO for IP program
CEO Jeffrey Parker awarded $71,000 cash bonus (25% of salary); CFO Cynthia French awarded $45,000 (25% of salary).
ParkerVision appoints Lewis Titterton as Class II director
Effective June 22, 2023, Titterton fills a board vacancy; he previously served from Sept 2018 to Apr 2019.
ParkerVision posts Q1 net income of $13.1M on $25M patent license revenue
Revenue of $25M from patent license/settlement agreements; net income $13.1M ($0.16/share) vs $0.3M ($0.00) YoY.
ParkerVision secures $5.0M additional funding from Brickell Key at lower interest rate
ParkerVision entered into a confidential letter agreement with Brickell Key Investments for $5.0M additional funding.
ParkerVision reports narrowed 2022 loss and $25M patent settlement in Q1 2023
Net loss for 2022 was $9.8M ($0.13/share), improved from $12.3M ($0.17/share) in 2021.
ParkerVision enters patent license and settlement agreement, expects $25M payment
On February 7, 2023, ParkerVision entered into a patent license and settlement agreement with a third-party.
Board approved performance bonus for CEO Jeffrey Parker: $40,000 cash and 200,000 restricted shares (grant-date fair value ~$60,000) that vest immediately.
ParkerVision issues $700K in convertible notes, $135K common stock; total $835K for operations
$500K convertible note issued Jan 11, 2023, convertible at $0.16/share, 9% interest, 5-year maturity with holder extension options.
ParkerVision raises $200K via issuance of 1M shares at $0.20 per share
Sold 1,000,000 shares of common stock at $0.20/share for gross proceeds of $200,000.
ParkerVision sells 1M shares at $0.20 each for $200K in private placement
Sold 1,000,000 common shares to accredited investor at $0.20/share; total proceeds $200,000.
ParkerVision settles patent litigation with Hisense; terms confidential
Patent license and settlement agreement with Hisense; litigation dismissed and IPR withdrawn.
ParkerVision expands board to 5, appoints Sanford M. Litvack as independent director
Board increased from 4 to 5 members; Litvack fills new vacancy as Class I director.
ParkerVision shareholders approve increase in authorized common stock to 175M shares
Authorized common stock increased from 150M to 175M shares; amendment effective Sept 19, 2022.
CFO Cynthia French receives $20k cash bonus and 166,390 restricted shares (fair value ~$30k) under 2019 LTIP.
ParkerVision issues $350K convertible notes at $0.13/share, 8% interest, due 2027
Company sold $350,000 aggregate face value of convertible notes to accredited investors on June 30, 2022.
On May 19, 2026, the Board unanimously appointed Anthony Bowers to fill the director vacancy created by Mr. Titterton’s resignation.
On May 15, 2026, Mr. Lewis Titterton resigned from the Board of Directors (the “Board”) of ParkerVision, Inc. (the "Company"), and from the Audit and Compensation Committees on which he served.
On April 15, 2025, Mr. Sanford Litvack resigned from our Board of Directors, and from the Audit and Compensation Committees on which he served.
Effective June 22, 2023, the Board of Directors of the Company appointed Lewis H. Titterton to fill a Class II director vacancy.
Effective the same date, the Board appointed Sanford M. Litvack to fill the newly created vacancy on the Company’s board of directors.
Max materiality 0.90 · Median 0.55 · Most common event other_material